Latest news for RBAZ Bancorp (OTC:RBAZ) Stock

RBAZ Bancorp Inc is a full service, community bank providing deposit and loan products and convenient, on-line and mobile banking to individuals, businesses and professionals.

RBAZ Bancorp Inc

Scotiabank analyst Nick Altmann maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Sector Perform and lowers the price target from $28 to $25.

News

Price Target

Analyst Ratings

CFLT

Scotiabank Maintains Sector Perform on Confluent, Lowers Price Target to $25

TD Cowen analyst Daniel Brennan maintains Standard BioTools (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NASDAQ">LAB</a>) with a Buy and lowers the price target from $3.5 to $2.75.

TD Cowen Maintains Buy on Standard BioTools, Lowers Price Target to $2.75

Citigroup analyst Ygal Arounian maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Buy and raises the price target from $64 to $65.

EBAY

Citigroup Maintains Buy on eBay, Raises Price Target to $65

TD Cowen analyst Bill Katz maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Buy and raises the price target from $145 to $154.

TD Cowen Maintains Buy on KKR, Raises Price Target to $154

TD Cowen analyst Moshe Orenbuch maintains Credit Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACC#NASDAQ">CACC</a>) with a Sell and lowers the price target from $440 to $400.

CACC

TD Cowen Maintains Sell on Credit Acceptance, Lowers Price Target to $400

Waters Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) reported upbeat second-quarter earnings, but lowered its<a href="https://www.benzinga.com/quote/WAT/earnings"> FY24 outlook on Wednesday</a>.
Waters reported quarterly earnings of $2.63 per share which beat the analyst consensus estimate of $2.56 per share. The company reported quarterly sales of $708.529 million which beat the analyst consensus estimate of $700.079 million.
&#8220;Our team executed well to deliver second quarter results that exceeded both our top-line and bottom-line reported guidance,&#8221; said Dr. Udit Batra, President &amp; CEO, Waters Corporation. &#8220;Our margins remained resilient, thanks to our disciplined approach to operational management, which offset headwinds from volume, currency, and inflation.&#8221;
Waters said it now sees FY24 adjusted earnings of $11.55 to $11.65 per share, versus earlier forecast of $11.75 to 12.05 per share. The company now expects sales growth outlook of -2.2% to -0.7%.
Waters shares gained 2.8% to trade at $345.82 on Thursday.
These analysts made changes to their price targets on Waters following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58cfe564b85e9300015ce42f/puneet-souda">Leerink Partners analyst Puneet Souda</a> upgraded Waters from Market Perform to Outperform and boosted the price target from $325 to $375.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e53ccccece4e600011fda74/justin-bowers">Deutsche Bank analyst Justin Bowers</a> maintained the stock with a Hold and lowered the price target from $330 to $310.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5ea2ec210cd8860001a1b1ce/luke-sergott">Barclays analyst Luke Sergott</a> maintained Waters with an Underweight rating, while raising the price target from $275 to $300.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter">Top 3 Health Care Stocks That Are Set To Fly This Quarter</a></li>
</ul>

Markets

Trading Ideas

These Analysts Revise Their Forecasts On Waters After Q2 Results

Citigroup analyst Ygal Arounian maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Neutral and raises the price target from $33 to $39.

MTCH

Citigroup Maintains Neutral on Match Group, Raises Price Target to $39

WIIM

SIRI

Sirius XM shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Everest Group shares are trading lower. The company reported worse-than-expected Q2 revenue results.

TD Cowen analyst Krish Sankar maintains OneSpaWorld Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSW#NASDAQ">OSW</a>) with a Buy and raises the price target from $16 to $19.

TD Cowen Maintains Buy on OneSpaWorld Holdings, Raises Price Target to $19

IDEX shares are trading lower after the company reported worse-than-expected Q2 earnings and FY Adjusted EPS guidance.

Citigroup analyst Andrew Gardiner maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and raises the price target from $150 to $170.

Citigroup Maintains Buy on ARM Holdings, Raises Price Target to $170

TTEK

Tetra Tech shares are trading higher after the company reported better-than-expected Q3 financial results. Also, Baird raised its price target on the stock from $223 to $230.

Shares of oil and gas stocks are trading lower. Weakness in the sector may be due to wore-than-expected US economic data, which could pressure demand outlook.

Arcelor Mittal shares are trading lower. The company reported worse-than-expected Q2 financial results.

Laboratory Corporation Of America Holdings

Labcorp shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates.

Citigroup analyst Anthony Pettinari maintains Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) with a Buy and raises the price target from $50 to $60.

SLGN

Citigroup Maintains Buy on Silgan Hldgs, Raises Price Target to $60

TD Cowen analyst Krish Sankar maintains Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) with a Buy and raises the price target from $1000 to $1050.

LRCX

TD Cowen Maintains Buy on Lam Research, Raises Price Target to $1050

TD Cowen analyst Matthew Ramsay maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and raises the price target from $125 to $150.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

RBAZ Bancorp

News

Latest news for RBAZ Bancorp (OTC:RBAZ) Stock